MRI-Cavernosography: A New Diagnostic Tool for Erectile Dysfunction Due to Venous Leakage: A Diagnostic Chance.

Autor: Di Serafino, Marco¹ (AUTHOR) iacobellisf@gmail.com, Pucci, Luigi² (AUTHOR) luigi.pucci@hotmail.it, Iacobellis, Francesca¹ (AUTHOR) roberto.ronza@hotmail.it, Fasbender Jacobitti, Marco² (AUTHOR) m.fasbenderjacobitti@gmail.com, Ronza, Roberto¹ (AUTHOR) vittorio.sabatino@gmail.com, Sabatino, Vittorio¹ (AUTHOR) dariogrimaldi@me.com, De Luca, Luigi² (AUTHOR) luigideluca86@gmail.com, Iossa, Vincenzo² (AUTHOR) vincenzoiossa@msn.com, Langella, Nunzio Alberto² (AUTHOR) nunzio.lang@gmail.com, Persico, Francesco² (AUTHOR) francesco.persico90@gmail.com, Grimaldi, Dario¹ (AUTHOR) marialaura.schilliro@gmail.com, Schillirò, Maria Laura¹ (AUTHOR) luca.lessoni@aocardarelli.it, Lessoni, Luca¹ (AUTHOR) maurizionotorio@libero.it, Notorio, Maurizio¹ (AUTHOR) luigia.romano1@gmail.com, Carrino, Maurizio² (AUTHOR) cris63@libero.it, Romano, Luigia¹ (AUTHOR)

Publikováno v: Diagnostics (2075-4418). Jul2023, Vol. 13 Issue 13, p2178. 14p.

Efficacy and safety profile of GreenLight laser photoselective vaporization of the prostate in ≥ 75 years old patients: results from the Italian GreenLight Laser Study Group.

Autor: Campobasso, Davide, Morselli, Simone, Greco, Francesco, De Nunzio, Cosimo, Destefanis, Paolo, Fasolis, Giuseppe, Varvello, Francesco, Voce, Salvatore, Reale, Giulio, Cai, Tommaso, Oriti, Rino, Tuccio, Agostino, Ruggera, Lorenzo, Laganà, Antonino, Dadone, Claudio, Gontero, Paolo, De Rienzo, Gaetano, Pucci, Luigi, Carrino, Maurizio, Montefiore, Franco

Publikováno v: Aging Clinical & Experimental Research; Apr2023, Vol. 35 Issue 4, p877-885, 9p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study)

Autor: Morgia, Giuseppe, Vespasiani, Giuseppe, Pareo, Rosaria M., Voce, Salvatore, Madonia, Massimo, Carini, Marco, Ingrassia, Antonio, Terrone, Carlo, Gentile, Marcello, Carrino, Maurizio, Giannantoni, Antonella, Blefari, Franco, Arnone, Salvatore, Santelli, Giorgio, Russo, Giorgio I., Reale, Giulio, Di Mauro, Marina, Fedelini, Paolo, Pucci, Luigi, Veneziano, Pasquale, Santaniello, Francesco, Ginepri, Andrea, Bitelli, Marco, Valerio Beatrici, M., Polledro, Patrizio, La Rosa, Pasquale, Chiancone, Francesco, Giannella, Riccardo, Del Fabbro, Dario, Farullo, Giuseppe, Cocci, Andrea, Lanciotti, Michele, Solinas, Tatiana, Di Dio, Agata, Dal Pozzo, Claudio, Palmieri, Fabiano, Zaganelli, Stefano, Lacetera, Vito

Publikováno v: BJU international. 122(2)

OBJECTIVE To compare in a randomised, open-label, non-inferiority clinical study, the efficacy and tolerability of Serenoa repens (SeR) + selenium (Se) + lycopene (Ly) (SeR-Se-Ly) therapy vs tadalafil 5 mg in men with lower urinary tract symptoms (LU

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d8e5642af68409ee1325bb7e69947c8
https://pubmed.ncbi.nlm.nih.gov/29569389